Get the latest Science News and Discoveries

Periostin shows promise to help fight a common form of esophageal cancer - EurekAlert


<p>Esophageal squamous cell carcinoma (ESCC) accounts for around 90% of esophageal cancers, especially in East Asia. New findings in <em>The American Journal of Pathology</em>, published by Elsevier, indicate that periostin, or POSTN, promotes ESCC progression by enhancing cancer and stromal cell migration in cancer-associated fibroblasts (CAFs). Therefore, it may be a novel therapeutic target for treating ESCC.</p>

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of esophageal cancer

esophageal cancer

Photo of common form

common form

Photo of EurekAlert

EurekAlert

Related news:

News photo

Avoidance, confusion, solitude: whales react to rising noise pollution - EurekAlert

News photo

Peregrine falcons expose lasting harms of flame retardant use - EurekAlert

News photo

Unlocking sweetness and ripeness: the pioneering study of SWI/SNF complexes in citrus fruit quality - EurekAlert